Medicare Enrolled

Dr. Kambiz Aflatoon, D.O.

Addiction Psychiatry Physician · Lawrenceville, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
250 SCENIC HWY, Lawrenceville, GA 30046
6784425851
Registered in NPPES since 2011
NPI: 1598032682 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aflatoon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aflatoon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aflatoon

Dr. Kambiz Aflatoon is an addiction psychiatry physician in Lawrenceville, GA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Aflatoon performed 596 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Aflatoon received a total of $4,815 from 30 pharmaceutical and/or device companies across 251 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aflatoon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years of NPI registration ▲ Top 22% volume in GA $4,815 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
596
Medicare services
Top 22% in GA for addiction psychiatry physician
Not available
Unique patients (not deduplicated)
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
181 $51 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
121 $94 $180
Psychotherapy session, 1 hour
A one-hour psychotherapy session involving talk therapy to address mental health concerns.
119 $106 $175
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
80 $64 $150
Drug test with direct observation
A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process.
63 $12 $20
Psychiatric services complicated by communication factor
Psychiatric evaluation or treatment provided when communication barriers complicate the interaction between the provider and the patient.
32 $11 $25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,815
Total received (2018-2024)
Avg $688/year across 7 years
Top 21% in GA for addiction psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
251
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$580
2023
$1,141
2022
$768
2021
$631
2020
$86
2019
$703
2018
$907

Payments by company (2024)

Janssen Pharmaceuticals, Inc
$120
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$103
ABBVIE INC.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$61
IDORSIA PHARMACEUTICALS US INC
$49
Lundbeck LLC
$43
Alkermes, Inc.
$30
Braeburn Inc.
$29
Teva Pharmaceuticals USA, Inc.
$23
Corium, LLC
$19
Otsuka America Pharmaceutical, Inc.
$17
Noven Therapeutics, LLC
$17
Top 3 companies account for 50.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$788
Indivior Inc.
$569
AbbVie Inc.
$471
Lundbeck LLC
$351
Sunovion Pharmaceuticals Inc.
$308
Takeda Pharmaceuticals U.S.A., Inc.
$294
Otsuka America Pharmaceutical, Inc.
$291
Alkermes, Inc.
$272
USWM, LLC
$247
ITI, Inc.
$225
ABBVIE INC.
$216
Orexo US, Inc.
$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$103
Supernus Pharmaceuticals, Inc.
$77
Noven Therapeutics, LLC
$70
IDORSIA PHARMACEUTICALS US INC
$61
Eisai Inc.
$58
Corium, LLC
$34
Vertical Pharmaceuticals, LLC
$31
Shire North American Group Inc
$29
Braeburn Inc.
$29
Teva Pharmaceuticals USA, Inc.
$23
Brainsway USA INC
$22
Neurocrine Biosciences, Inc.
$20
US WorldMeds, LLC
$17
OWP Pharmaceuticals, Inc.
$16
Neos Therapeutics, LP
$15
Allergan Inc.
$15
Kaleo, Inc.
$11
Neuronetics, Inc.
$11
Top 3 companies account for 38.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ARISTADA · Adzenys XR-ODT · Aristada 441 mg · Azstarys · BRINTELLIX · BRIXADI · CAPLYTA · Dayvigo · Evzio · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · LATUDA · Lamotrigine Starter Kit · Lucemyra · Lucemyra/Lofexidine · MYDAYIS · NEUROSTAR TMS THERAPY · OSMOLEX ER · QELBREE · QUVIVIQ · RELEXXII · REXULTI · SECUADO · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · TRINTELLIX · Trintellix · UZEDY · Uloric · VIVITROL · VRAYLAR · Vivitrol · Vivitrol 380 mg · Xelstrym · ZIMHI · Zubsolv
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an addiction psychiatry physician in Lawrenceville?
Compare addiction psychiatry physicians in the Lawrenceville area by procedure volume, costs, and industry payment transparency.
Browse addiction psychiatry physicians nearby

Geographic Context

Addiction psychiatry physicians in nearby ZIP areas
14
County median income
$84,823
Nearest hospital to ZIP centroid (approximate)
SUMMITRIDGE CENTER- PSYCHIATRY & ADDICTIVE MED
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Aflatoon is a clinical cardiology specialist, with above-average Medicare volume (top 22% in GA).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Aflatoon experienced with psychotherapy and evaluation, 30 minutes?
Based on Medicare claims data, Dr. Aflatoon performed 181 psychotherapy and evaluation, 30 minutes services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Aflatoon receive payments from pharmaceutical companies?
Yes. Dr. Aflatoon received a total of $4,815 from 30 companies across 251 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aflatoon's costs compare to other addiction psychiatry physicians in Lawrenceville?
Dr. Aflatoon's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aflatoon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →